Variable | VAC therapy | Conventional treatment | p value | ||
---|---|---|---|---|---|
n | % | n | % | ||
Number of patients | 47 | 52.2 | 43 | 47.8 | |
Sex | |||||
Male | 12 | 25.3 | 21 | 48.8 | 0.003** |
Female | 35 | 74.7 | 22 | 51.2 | 0.003** |
Surgical procedure | |||||
Isolated or combined CABG procedure | 32 | 68.1 | 29 | 67.4 | 0.262 |
Isolated valvular procedure | 15 | 31.9 | 14 | 32.6 | 0.302 |
Diabetes mellitus | 15 | 31.9 | 14 | 32.6 | 0.255 |
Obesity (BMI ≥ 30) | 33 | 70.2 | 22 | 51.2 | 0.043** |
LVEF ≤ 0.30 | 10 | 21.3 | 11 | 25.6 | 0.116 |
NYHA Class III–IV | 19 | 40.4 | 13 | 30.2 | 0.078 |
COPD | 9 | 19.1 | 8 | 18.6 | 0.298 |
Age > 65 years | 26 | 55.3 | 13 | 30.2 | 0.004** |
Renal failure* | 2 | 4.3 | 1 | 2.3 | 0.065 |
Emergency surgery | 7 | 14.9 | 5 | 11.6 | 0.122 |
Re-do surgery | 4 | 8.5 | 3 | 6.9 | 0.190 |
Re-exploration | 9 | 19.1 | 5 | 11.6 | 0.053 |
Post perfusion syndrome | 13 | 27.7 | 10 | 23.2 | 0.272 |
Prolonged mechanical ventilation | 21 | 44.7 | 16 | 37.2 | 0.185 |
ICU stay > 2 days | 19 | 40.4 | 20 | 46.5 | 0.197 |
Prolonged use of inotropic drugs | 20 | 42.6 | 17 | 39.5 | 0.177 |
Immunosuppression | 1 | 2.1 | 1 | 2.3 | 0.344 |
Mean | SD | Mean | SD | ||
CPB time (minutes) | 119 | 33.18 | 123.1 | 28.28 | 0.150 |
X-clamp time (minutes) | 98.2 | 28.08 | 99.3 | 14.14 | 0.313 |
Age (y) | 67.96 | 10.47 | 57.3 | 14.7 | 0.004** |
EuroSCORE | 7.5 | 3.4 | 5.0 | 2.6 | <0.001** |